|
RSC1A1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.82204999999991E-05 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.761900E-04 |
| Normal-vs-Stage2 |
9.881200E-03 |
| Normal-vs-Stage3 |
2.97449999997479E-06 |
| Normal-vs-Stage4 |
1.23490000003557E-06 |
| Stage1-vs-Stage2 |
8.562600E-01 |
| Stage1-vs-Stage3 |
1.467020E-01 |
| Stage1-vs-Stage4 |
3.206300E-02 |
| Stage2-vs-Stage3 |
2.479800E-01 |
| Stage2-vs-Stage4 |
1.216390E-01 |
| Stage3-vs-Stage4 |
5.054600E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.63860000000194E-05 |
| Normal-vs-AfricanAmerican |
4.176000E-02 |
| Normal-vs-Asian |
2.3521999999998E-05 |
| Caucasian-vs-AfricanAmerican |
5.143200E-01 |
| Caucasian-vs-Asian |
2.199000E-01 |
| AfricanAmerican-vs-Asian |
1.384240E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
7.75570000000059E-07 |
| Normal-vs-Female |
1.238360E-04 |
| Male-vs-Female |
8.889600E-02 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
9.392900E-04 |
| Normal-vs-Age(41-60Yrs) |
4.27920000000137E-05 |
| Normal-vs-Age(61-80Yrs) |
1.75556999999493E-05 |
| Normal-vs-Age(81-100Yrs) |
1.250260E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.436600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.796390E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.392400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.514200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.712400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.106200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
3.412200E-02 |
| Classical-VS-Follicular |
1.892570E-01 |
| Classical-VS-Other |
2.922200E-03 |
| Classical-VS-Normal |
3.599900E-04 |
| Tall-VS-Follicular |
3.812200E-01 |
| Tall-VS-Other |
2.361800E-01 |
| Tall-VS-Normal |
5.73520000000105E-05 |
| Follicular-VS-Other |
2.130200E-02 |
| Follicular-VS-Normal |
1.954780E-04 |
| Other-VS-Normal |
4.39890000003551E-06 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.55559999999566E-05 |
| Normal-vs-N1 |
2.14619999999721E-05 |
| N0-vs-N1 |
2.732000E-01 |
|
|
